|
|
|
Insider
Information: |
Love Richard L |
Relationship: |
Director |
City: |
San Antonio |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
122,528 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$670,126 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
122,528 |
|
|
Total
Value |
$670,126 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
PAREXEL International |
PRXL |
Director |
2017-09-29 |
0 |
2003-10-24 |
0 |
Premium* |
|
Imarx Therapeutics Inc |
SEGI |
Director |
2008-05-30 |
48,810 |
2007-07-26 |
0 |
Premium* |
|
Cti Biopharma Corporation |
CTIC |
Director |
2017-09-29 |
73,718 |
2007-09-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CTIC |
Cti Biopharma Corporation |
Director |
|
2009-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,451,513 |
4,532,113 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2010-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
996,661 |
2,432,773 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2009-11-24 |
4 |
A |
$0.00 |
$0 |
D/D |
653,690 |
1,511,112 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
516,360 |
933,004 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2009-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
321,839 |
402,439 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2009-11-13 |
4 |
A |
$0.00 |
$0 |
D/D |
290,017 |
857,422 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2011-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
187,292 |
582,753 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2011-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(166,109) |
416,644 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2014-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
146,000 |
549,265 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2011-03-21 |
4/A |
A |
$0.44 |
$54,375 |
D/D |
125,000 |
2,352,773 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2013-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
109,891 |
345,308 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2017-09-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(88,302) |
0 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2013-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
86,957 |
409,265 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2010-08-23 |
4 |
AS |
$0.37 |
$27,885 |
D/D |
(75,000) |
2,357,773 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2010-11-22 |
4 |
AS |
$0.38 |
$28,919 |
D/D |
(75,000) |
2,302,773 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2011-02-22 |
4 |
AS |
$0.29 |
$22,402 |
D/D |
(75,000) |
2,227,773 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2012-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
71,429 |
263,510 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2009-08-12 |
4 |
S |
$1.64 |
$114,800 |
D/D |
(70,000) |
547,405 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2010-05-24 |
4 |
AS |
$0.33 |
$22,209 |
D/D |
(63,700) |
1,447,412 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2016-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
63,695 |
535,824 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2015-12-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(58,320) |
472,129 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2007-12-27 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
546,996 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
Director |
|
2014-03-07 |
4 |
S |
$3.75 |
$150,973 |
D/D |
(40,000) |
509,265 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2012-02-06 |
4 |
AS |
$24.77 |
$866,950 |
D/D |
(35,000) |
100,530 |
0 |
- |
|
PRXL |
PAREXEL International |
Director |
|
2012-02-06 |
4 |
OE |
$8.60 |
$352,890 |
D/D |
35,000 |
135,530 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|